Neuro-Oncology Reviews
Volume
25 Number 17
15 September 2023
Home > Publications > Neuro-Oncology Reviews > Volume 25, Year 2023 > Number 17, 15 September
Diaz S, Reyns N, Özduman K,
Levivier M, Schulder M, Tuleasca C.
Microsurgical
resection of gliomas of the cingulate gyrus: a systematic review
and meta-analysis.
Neurosurg
Rev. 2023 Sep 1;46(1):217∟.
doi: 10.1007/s10143-023-02127-9∟.
PMID: 37656287∟.
Review, Meta-analysis. ˍ
Gu X, He X, Wang H, Li J, Chen R,
Liu H.
Dynamic
Susceptibility Contrast-Enhanced Perfusion-Weighted Imaging in
Differentiation Between Recurrence and Pseudoprogression in
High-Grade Glioma: A Meta-analysis.
J
Comput Assist Tomogr. 2023 Sep 1∟.
doi: 10.1097/RCT.0000000000001543∟.
PMID: 37654056∟.
Meta-analysis˰ ˍ
Pournajaf S, Afsordeh N,
Pourgholami MH.
In
vivo C6
glioma models: an update and a guide toward a more effective
preclinical evaluation of potential anti-glioblastoma drugs.
Rev
Neurosci. 2023 Sep 1∟.
doi: 10.1515/revneuro-2023-0067? PMID: 37651618∟.
Review˰ ˍ
Bertero L, Mangherini L, Ricci AA,
Cassoni P, Sahm F.
Molecular
neuropathology: an essential and evolving toolbox for the
diagnosis and clinical management of central nervous system
tumors.
Virchows
Arch. 2023 Sep 2∟.
doi: 10.1007/s00428-023-03632-4∟.
PMID: 37658995∟.
Review. ˍ
Li X, Liu K, Xing L, Rubinsky B.
A
review of tumor treating fields (TTFields): advancements in
clinical applications and mechanistic insights.
Radiol
Oncol. 2023 Sep 4;57(3):279-291∟.
doi: 10.2478/raon-2023-0044∟.
PMID: 37665740∟.
Review. ˍ
Lucerón-Lucas-Torres M,
Cavero-Redondo I, Martínez-Vizcaíno V,
Bizzozero-Peroni B, Pascual-Morena C, Álvarez-Bueno
C.
Association
between wine consumption
and cancer: a systematic review and meta-analysis.
Front
Nutr. 2023 Sep
4;10:1197745∟.
doi: 10.3389/fnut.2023.1197745∟.
PMID: 37731399∟.
Review, Meta-analysis. ˍ
*
Oster C, Schmidt T, Agkatsev S,
Lazaridis L, Kleinschnitz C, Sure U, Scheffler B, Kebir S, Glas
M.
Are
we providing best-available care to newly diagnosed glioblastoma
patients? Systematic review of phase III trials in newly diagnosed
glioblastoma 2005-2022.
Neurooncol
Adv. 2023 Sep 4;5(1):vdad105∟.
doi: 10.1093/noajnl/vdad105∟.
PMID: 37811538∟.
Review. ˍ
Zhang L, Jiang Y, Zhang G, Wei
S.
The
diversity and dynamics of tumor-associated macrophages in
recurrent glioblastoma.
Front
Immunol. 2023 Sep 4;14:1238233∟.
doi: 10.3389/fimmu.2023.1238233∟.
PMID: 37731483∟.
Review. ˍ
Alizadeh M, Broomand Lomer N, Azami
M, Khalafi M, Shobeiri P, Arab Bafrani M, Sotoudeh H.
Radiomics:
The New Promise for Differentiating Progression, Recurrence,
Pseudoprogression, and Radionecrosis in Glioma and Glioblastoma
Multiforme.
Cancers
(Basel). 2023 Sep 5;15(18):4429∟.
doi: 10.3390/cancers15184429∟.
PMID: 37760399∟.
Review. ˍ
Esteban-Rodríguez I,
López-Muñoz S, Blasco-Santana L, Mejías-Bielsa
J, Gordillo CH, Jiménez-Heffernan JA.
Cytological
features of diffuse and circumscribed gliomas.
Cytopathology.
2023 Sep 5∟.
doi: 10.1111/cyt.13300∟.
PMID: 37668299∟.
Review˰ ˍ
Li F, Wu H, Du X, Sun Y, Rausseo
BN, Talukder A, Katailiha A, Elzohary L, Wang Y, Wang Z, Lizée
G.
Epidermal
Growth Factor Receptor-Targeted Neoantigen Peptide Vaccination for
the Treatment of Non-Small Cell Lung Cancer and
Glioblastoma.
Vaccines
(Basel). 2023 Sep 5;11(9):1460∟.
doi: 10.3390/vaccines11091460∟.
PMID: 37766136∟.
Review. ˍ
Pasquini L, Peck KK, Jenabi M,
Holodny A.
Functional
MRI in Neuro-Oncology: State of the Art and Future
Directions.
Radiology.
2023 Sep 5;308(3):e222028∟.
doi: 10.1148/radiol.222028∟.
PMID: 37668519∟.
Review. ˍ
Bocanegra-Becerra JE, Batista S,
Costa Vieitas F, Takahashi R, Oliveira LB, Castillo-Huerta NM,
Ludeña-Esquivel A, Bertani R.
Awake
surgery for glioma resection during pregnancy: a systematic
review.
Neurosurg
Rev. 2023 Sep 6;46(1):228∟.
doi: 10.1007/s10143-023-02135-9∟.
PMID: 37674009∟.
Review˰ ˍ
Gimple RC, Prager BC, Xie Q.
Editorial:
Epigenetic and metabolic regulation of primary and metastatic
brain cancers.
Front Oncol. 2023 Sep 7;13:1271851∟.
doi: 10.3389/fonc.2023.1271851∟.
PMID: 37746272∟.
Editorial. ˍ
Joyce T, Jagasia S, Tasci E,
Camphausen K, Krauze AV.
An
Overview of CD133 as a Functional Unit of Prognosis and Treatment
Resistance in Glioblastoma.
Curr
Oncol. 2023 Sep 7;30(9):8278-8293∟.
doi: 10.3390/curroncol30090601∟.
PMID: 37754516∟.
Review. ˍ
Sulman EP, Eisenstat DD.
Editorial:
365 days of progress in neuro-oncology and neurosurgical
oncology.
Front
Oncol. 2023 Sep 7;13:1279957∟.
doi: 10.3389/fonc.2023.1279957∟.
PMID: 37746263∟.
Editorial. ˍ
Yasinjan F, Xing Y, Geng H, Guo R,
Yang L, Liu Z, Wang H.
Immunotherapy:
a promising approach for glioma treatment.
Front
Immunol. 2023 Sep 7;14:1255611∟. doi:
10.3389/fimmu.2023.1255611∟.
PMID: 37744349∟.
Review. ˍ
Ahmed MH, Canney M, Carpentier A,
Thanou M, Idbaih A.
Unveiling
the enigma of the blood-brain barrier in glioblastoma: current
advances from preclinical and clinical studies.
Curr
Opin Oncol. 2023 Sep 8∟.
doi: 10.1097/CCO.0000000000000990∟.
PMID: 37681417∟.
Review. ˍ
Bartusik-Aebisher D, Woźnicki
P, Dynarowicz K, Aebisher D.
Photosensitizers
for Photodynamic Therapy of Brain Cancers-A Review.
Brain
Sci. 2023 Sep 8;13(9):1299∟.
doi: 10.3390/brainsci13091299∟.
PMID: 37759900∟.
Review. ˍ
Dalmage M, LoPresti MA, Sarkar P,
Ranganathan S, Abdelmageed S, Pagadala M, Shlobin
NA, Lam S, DeCuypere M.
Survival
and neurological outcomes after
stereotactic
biopsy of diffuse intrinsic pontine glioma: a systematic review.
J
Neurosurg Pediatr. 2023 Sep 8:1-8∟.
doi: 10.3171/2023.7.PEDS22462∟.
PMID: 37724839∟.
Review˰ ˍ
Formentin C, Joaquim AF, Ghizoni
E.
Posterior
fossa tumors in children: current insights.
Eur
J Pediatr. 2023 Sep 8∟.
doi: 10.1007/s00431-023-05189-5∟.
PMID: 37679511∟.
Review˰ ˍ
McDonald B, Barth K, Schmidt
MHH.
The
origin of brain malignancies at the blood-brain barrier.
Cell
Mol Life Sci. 2023 Sep 9;80(10):282∟.
doi: 10.1007/s00018-023-04934-1∟.
PMID: 37688612∟.
Review. ˍ
Liang T, Song Y, Gu L, Wang Y, Ma
W.
Insight
into the Progress in CAR-T Cell
Therapy
and Combination with Other Therapies for Glioblastoma.
Int
J Gen Med. 2023 Sep
11;16:4121-4141∟.
doi: 10.2147/IJGM.S418837∟.
PMID: 37720174∟.
Review. ˍ
Otero JJ.
The
Cognitive Framework Behind Modern Neuropathology.
Arch
Pathol Lab Med. 2023 Sep 11∟.
doi: 10.5858/arpa.2023-0209-RA∟.
PMID: 37694567∟.
Perspective. ˍ
Avila EK, Tobochnik S, Inati SK,
Koekkoek JAF, McKhann GM, Riviello JJ, Rudà R, Schiff D,
Tatum WO, Templer JW, Weller M, Wen PY.
Brain
tumor-related epilepsy management: A Society for Neuro-oncology
(SNO) consensus review on current management.
Neuro
Oncol. 2023 Sep 12:noad154∟.
doi: 10.1093/neuonc/noad154∟.
PMID: 37699031∟.
Review. ˍ
*
Chen C, Du X, Yang L, Liu H, Li Z,
Gou Z, Qi J.
Research
on application of radiomics in glioma: a bibliometric and visual
analysis.
Front
Oncol. 2023 Sep 12;13:1083080∟.
doi: 10.3389/fonc.2023.1083080∟.
PMID: 37771434∟.
Bibliometric
analysis. ˍ
Chen Y, Qu W, Tu J, Qi
H.
Implications
of Advances in Studies of O6-Methylguanine-DNA-
Methyltransferase for Tumor Prognosis and Treatment.
Front
Biosci (Landmark Ed). 2023 Sep 12;28(9):197∟.
doi: 10.31083/j.fbl2809197∟.
PMID: 37796680∟.
Review. ˍ
Tang OY, Binder ZA, O'Rourke DM,
Bagley SJ.
Optimizing
CAR-T Therapy for Glioblastoma.
Mol
Diagn Ther. 2023 Sep 12∟.
doi: 10.1007/s40291-023-00671-0∟.
PMID: 37700186∟.
Review˰ ˍ
Wang Q, Xin X, Dai Q, Sun M, Chen
J, Mostafavi E, Shen Y, Li X.
Medulloblastoma
targeted therapy: From signaling pathways heterogeneity and
current treatment dilemma to the recent advances in development of
therapeutic strategies.
Pharmacol
Ther. 2023 Sep 12;250:108527∟.
doi: 10.1016/j.pharmthera.2023.108527∟.
PMID: 37703952∟.
Review˰ ˍ
Ge Z, Zhang Q, Lin W, Jiang X,
Zhang Y.
The
role of angiogenic growth factors
in the
immune microenvironment of glioma.
Front
Oncol. 2023 Sep 13;13:1254694∟.
doi: 10.3389/fonc.2023.1254694∟.
PMID: 37790751∟.
Review. ˍ
Liu KX, Haas-Kogan DA, Elhalawani
H.
Radiotherapy
for Primary Pediatric Central Nervous System Malignancies: Current
Treatment Paradigms and Future Directions.
Pediatr
Neurosurg. 2023 Sep 13∟.
doi: 10.1159/000533777? PMID: 37703864∟.
Review. ˍ
Ramakrishnan D, von Reppert M,
Krycia M, Sala M, Mueller S, Aneja S, Nabavizadeh A, Galldiks N,
Lohmann P, Raji C, Ikuta I, Memon F, Weinberg BD, Aboian
MS.
Evolution
and implementation of radiographic response criteria in
neuro-oncology.
Neurooncol
Adv. 2023 Sep 13;5(1):vdad118∟.
doi: 10.1093/noajnl/vdad118∟.
PMID: 37860269∟.
Review. ˍ
Ribeiro M, Yordanova YN, Noblet V,
Herbet G, Ricard D.
White
matter tracts and executive functions: a review of causal and
correlation evidence.
Brain.
2023 Sep 13:awad308∟.
doi: 10.1093/brain/awad308∟.
PMID: 37703295∟.
Review˰ ˍ
Sailunaz K, Alhajj S, Özyer T,
Rokne J, Alhajj R.
A
survey on brain tumor image analysis.
Med
Biol Eng Comput. 2023 Sep 13∟.
doi: 10.1007/s11517-023-02873-4∟.
PMID: 37700082∟.
Review˰ ˍ
Tang J, Dong Z, Sheng J, Yang P,
Zhao W, Xue J, Li Q, Lv L, Lv X.
Advances
in the relationship between temporal muscle thickness and
prognosis of patients with glioblastoma: a narrative review.
Front
Oncol. 2023 Sep 13;13:1251662∟.
doi: 10.3389/fonc.2023.1251662∟.
PMID: 37771443∟.
Review. ˍ
Weiser A, Sanchez Bergman A,
Machaalani C, Bennett J, Roth P, Reimann RR, Nazarian J, Guerreiro
Stucklin AS.
Bridging
the age gap: a review of molecularly informed treatments for
glioma in adolescents and young adults.
Front
Oncol. 2023 Sep 13;13:1254645∟.
doi: 10.3389/fonc.2023.1254645∟.
PMID: 37781183∟.
Review. ˍ
Chen M, Bie L, Ying J.
Cancer
cell-intrinsic PD-1: Its role in malignant
progression
and immunotherapy.
Biomed
Pharmacother. 2023 Sep 14;167:115514∟.
doi: 10.1016/j.biopha.2023.115514∟.
PMID: 37716115∟.
Review. ˍ
Li WS, Zhang QQ, Li Q, Liu SY, Yuan
GQ, Pan YW.
Innate
immune response restarts adaptive immune response in tumors.
Front
Immunol. 2023 Sep 14;14:1260705∟.
doi: 10.3389/fimmu.2023.1260705∟.
PMID: 37781382∟.
Review. ˍ
Morales CS, Grodzinski P.
Current
landscape of treating different cancers using nanomedicines:
Trends and perspectives.
Wiley
Interdiscip Rev Nanomed Nanobiotechnol. 2023 Sep 14:e1927∟.
doi: 10.1002/wnan.1927∟.
PMID: 37706362∟.
Review˰ ˍ
Zheng Y, Ma X, Feng S, Zhu H, Chen
X, Yu X, Shu K, Zhang S.
Dendritic
cell vaccine
of gliomas: challenges from bench to bed.
Front
Immunol. 2023 Sep 14;14:1259562∟.
doi: 10.3389/fimmu.2023.1259562∟.
PMID: 37781367∟.
Review. ˍ
Zhou S, Sun H, Choi SI, Yin
J.
Present
Status and Advances in Chimeric Antigen Receptor T Cell Therapy
for Glioblastoma.
Front
Biosci (Landmark Ed). 2023 Sep 15;28(9):206∟.
doi: 10.31083/j.fbl2809206∟.
PMID: 37796692∟.
Review. ˍ